ANKRD53_Ankrd53 Inhibitors
ANKRD53/Ankrd53 inhibitors are a class of chemical compounds developed to target and inhibit the ANKRD53 (Ankrd53) protein, which is part of the ankyrin repeat domain-containing protein family. These proteins are characterized by the presence of ankyrin repeat motifs, which are repetitive structural units that facilitate protein-protein interactions. ANKRD53 is believed to play a role in various cellular processes, including signal transduction, structural organization, and regulation of intracellular pathways. The ankyrin repeats in ANKRD53 provide a scaffold for interacting with other proteins, enabling it to form complexes that are essential for its function. Inhibitors of ANKRD53 are designed to interfere with these interactions, preventing the protein from binding to its partners and disrupting its role in cellular functions.
Chemically, ANKRD53 inhibitors can take the form of small molecules, peptides, or synthetic compounds specifically engineered to bind to the ankyrin repeat domains of the protein. These inhibitors may block the protein's natural binding sites, occupying the regions critical for protein-protein interactions, thereby preventing ANKRD53 from associating with its interacting partners. Some inhibitors may work by inducing conformational changes that destabilize the ankyrin repeat structure, hindering its ability to maintain its functional form. Others may compete with natural ligands of ANKRD53, effectively disrupting the protein's role in forming complexes with other cellular components. By inhibiting ANKRD53, these compounds serve as important tools for studying the functional role of ankyrin repeat domains in cellular regulation and the specific molecular mechanisms mediated by ANKRD53 in various biological pathways.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. ANKRD53's function can be inhibited by staurosporine through its action on kinase activity, potentially altering phosphorylation states that are critical for ANKRD53's function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I inhibits protein kinase C (PKC). Since PKC can phosphorylate a variety of proteins, its inhibition can lead to a decrease in the phosphorylation state of ANKRD53, thus reducing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, LY294002 can decrease downstream Akt signaling, which may be involved in the functional regulation of ANKRD53, leading to its inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can inhibit the PI3K/Akt pathway. This inhibition can reduce the functional activity of proteins regulated by this pathway, including ANKRD53. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. By inhibiting MEK, PD98059 can prevent the activation of ERK and subsequent phosphorylation of proteins, potentially including ANKRD53, leading to its inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By specifically inhibiting p38 MAPK, this compound can disrupt downstream signaling that may involve phosphorylation events relevant to ANKRD53's activity, resulting in inhibition of ANKRD53. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAPK pathway. Inhibition of JNK can lead to reduced phosphorylation of associated proteins, which could impair ANKRD53's functional role in the cell. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which can prevent the activation of the MAPK/ERK pathway. Through this action, U0126 can inhibit the functional activity of proteins involved in this pathway, including ANKRD53. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, affecting the actin cytoskeleton. By inhibiting ROCK, Y-27632 can lead to changes in cytoskeletal dynamics, potentially inhibiting the functional activity of ANKRD53 related to cytoskeletal regulation. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src family kinases can regulate various signaling pathways, including those involving phosphorylation. Inhibition by PP2 can reduce the functional activity of proteins like ANKRD53. | ||||||